BiVictrix Therapeutics Plc

Pheon Therapeutics

The company develops antibody-drug conjugates to treat solid tumours for the healthcare and pharmaceutical sectors.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

Promatix

Promatix develops antibody-drug conjugates for cancer treatment using a proprietary multi-omics platform to identify and target specific tumour markers.

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.

Adcendo

This clinical-stage biotechnology company develops antibody-drug conjugates to treat patients with various types of cancer and high unmet medical needs.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

araris

This company develops antibody-drug conjugate linker technology to create targeted cancer therapies for the pharmaceutical and biotechnology industries.